1 / 1

-200 pb

A. CpG site. 8. 7. 6. 5. 4. 3. 2. 1. +1. XAF1 gene. -200 pb . -100 pb. P2. P1. 1. 2. 3. 4. 5. 6. 7. 8. CpG Site:. B. Control-1. Control-2. SF295. NT. Glioblastoma. SF539. IFN– b 24 h. Cervical carcinoma. HeLa. Neuroblastoma. SK-N-AS. C. E. 100. SF295.

Download Presentation

-200 pb

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. A CpG site 8 7 6 5 4 3 2 1 +1 XAF1 gene -200 pb -100 pb P2 P1 1 2 3 4 5 6 7 8 CpG Site: B Control-1 Control-2 SF295 NT Glioblastoma SF539 IFN–b 24 h Cervical carcinoma HeLa Neuroblastoma SK-N-AS C E 100 SF295 SF539 80 NT 24h NT 24h 60 Average methylation Within XAF1 promoter (%) XAF1 40 SF295 SF539 20 b-actin 0 SK-N-AS HeLa SF295 SF539 Control NT IFN D F 5-AZA-dC 5-AZA-dC 3500 NT IFN 20nM 50 nM 100nM 20nM 50 nM 100nM 3000 XAF1 SF295 2500 b-actin Fold XAF1 transcript induction (XAF1/GAPDH) 2000 1500 XAF1 HeLa 1000 b-actin 500 0 SK-N-AS HeLa

More Related